All Stories

  1. Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose
  2. Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model
  3. Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome
  4. Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
  5. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia
  6. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
  7. Clinical significance of pre-transplant circulating CD3+CD4+CD161+cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation
  8. Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment
  9. Allogeneic Stem Cell Transplantation Outcomes in Acute Myeloid Leukemia Patients with t(8;21)(q22;q22) in First Remission According to Conditioning Regimen
  10. Mixed-phenotype acute leukemia (MPAL) and beyond
  11. Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant
  12. Determination of posaconazole concentration with LC–MS/MS in adult patients with hematologic malignancy
  13. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment
  14. Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations
  15. Humanized (SCID) Mice as a Model to Study human Leukemia
  16. Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup usingWT1expression in association withNPM1andFLT3-ITD mutations
  17. Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy
  18. Feasible Outcomes of T Cell–Replete Haploidentical Stem Cell Transplantation with Reduced-Intensity Conditioning in Patients with Myelodysplastic Syndrome
  19. (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia
  20. Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia
  21. FLT3 expression and IL10 promoter polymorphism in acute myeloid leukemia with RUNX1-RUNX1T1
  22. Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis
  23. HLA Mismatch Allogeneic Blood and Marrow Transplantation
  24. How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML
  25. Acute myeloid leukemia associated with FGFR1 abnormalities
  26. Variant of ETV6/ABL1 Gene Is Associated with Leukemia Phenotype
  27. Posaconazole Treatment in Korea: Single-Center Experience Over 5 Years
  28. Clinical characteristics and the usefulness of the QuantiFERON-TB Gold In-Tube test in hematologic patients with hepatic or splenic lesions
  29. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit
  30. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement
  31. Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category
  32. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia
  33. The premier statistical report of hematologic malignancies in Korea
  34. Prognosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases in Korea
  35. Inertial blood plasma separation in a contraction–expansion array microchannel
  36. Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients
  37. Fortuitous detection of esophageal pneumatosis in a neutropenic patient
  38. A Case of Pseudomembranous Colitis after Voriconazole Therapy
  39. Vitamin B12-Responsive Pancytopenia Mimicking Myelodysplastic Syndrome
  40. A Case of Disseminated Aspergillosis Presenting Solely as Multiple Cutaneous Lesions in an Acute Leukemia Patient
  41. Mutations in AML with a normal karyotype:NPM1andFLT3-ITD, ready to use as a key prognosticator?
  42. JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
  43. Characteristics of Cytomegalovirus Diseases among Hematopoietic Stem Cell Transplant Recipients : A 10-year Experience at an University Hospital in Korea
  44. HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation
  45. Distributions of HLA Microsatellite Markers and the Linkage Disequilibria between HLA and Microsatellites in Koreans
  46. Susceptibility of Leukemia according to the Genotype of Minor Histocompatibility Antigens in a Korean Population
  47. Effect of Extracorporeal Photopheresis on Steroid Resistant Acute GVHD Refractory to High Dose Steroid Treatment
  48. Hematopoietic Stem Cell Transplantation with Using Multinational Unrelated Donors for Acute Myelogenous Leukemia
  49. A Case of Therapy-related Acute Myeloid Leukemia associated with inv(16)
  50. Risk-Adapted Preemptive Therapy for Cytomegalovirus Disease after Allogeneic Stem Cell Transplantation: A Single-Center Experience in Korea
  51. Clinical Characteristics and Outcomes of Posttransplant Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation in Korea
  52. A Case of Acute Myeloid Leukemia with Masked t(8;21)
  53. Fas, Fas-Associated Death Domain-Like Interleukin 1β -Converting Enzyme-Like Inhibitory Protein, and Apoptotic Features of Elderly Acute Myeloid Leukemia Based on Response to Induction Chemotherapy
  54. Risk-Adapted Preemptive Therapy for Cytomegalovirus Disease after Allogeneic Stem Cell Transplantation: A Single-Center Experience in Korea
  55. Megadose CD34+Hemopoietic Stem Cell Transplantation for Patients with High Risk Acute Myeloid Leukemia Who Have No HLA Matched Donor - A Pilot Study of a Full Haplotype Mismatch Transplantation -
  56. Very Severe Aplastic Anemia appearing after Thymectomy
  57. The Association of HLA Antigen and GVHD in Allogeneic Hemopoietic Stem Cell Transplantation with Histocompatible Sibling Donor: A Single-Center Experience in Korea
  58. Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML
  59. Selective Bowel Decontamination for the Prevention of Infection in Acute Myelogenous Leukemia - A Prospective Randomized Trial